Top Markets
#1 OSK OSK +15.45%
#2 HOME HOME +8.41%
#3 Tornado Cash Tornado Cash +6.73%
#4 UnifAI Network UnifAI Network +6.16%
#5 MarsCoin MarsCoin +5.46%
#6 Nesa Nesa +5.10%
#7 Cash Cat Cash Cat +4.14%
#8 Biconomy Biconomy +4.03%
#9 Story Story +3.66%
#10 Prom Prom +3.35%
Coin of the day
OSK OSK
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Rankning i aktier #16435
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Aktiekurs
$4.64
Senast synkroniserad: 2022-09-12
Marknadsvärde
$293.43M
Förändring (1 dag)
0.87%
Förändring (1 år)
0.00%
Land
US
Handel Adagio Therapeutics, Inc. (ADGI)

Kategori

Healthcare
Aktiekurshistorik för Adagio Therapeutics, Inc. (ADGI)
Högsta slutkurs: $4.63 den 2022-09-01

Lägsta slutkurs: $27.68 den 2021-08-01
Aktiekurshistorik för Adagio Therapeutics, Inc. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2022 -78.16%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.41 -10.62%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 6.90%
CH